BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 34676001)

  • 21. Emerging Recombinant Oncolytic Poliovirus Therapies Against Malignant Glioma: A Review.
    Dighe OR; Korde P; Bisen YT; Iratwar S; Kesharwani A; Vardhan S; Singh A
    Cureus; 2023 Jan; 15(1):e34028. PubMed ID: 36814733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disentangling the therapeutic tactics in GBM: From bench to bedside and beyond.
    Daisy Precilla S; Kuduvalli SS; Thirugnanasambandhar Sivasubramanian A
    Cell Biol Int; 2021 Jan; 45(1):18-53. PubMed ID: 33049091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of newly diagnosed glioblastoma multiforme: current state of the art and emerging therapeutic approaches.
    McMahon DJ; Gleeson JP; O'Reilly S; Bambury RM
    Med Oncol; 2022 Jun; 39(9):129. PubMed ID: 35716200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineered Aurotherapy for the Multimodal Treatment of Glioblastoma.
    Kim HS; Lee DY
    Brain Tumor Res Treat; 2022 Oct; 10(4):215-220. PubMed ID: 36347635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioblastoma Multiforme-A Look at the Past and a Glance at the Future.
    King JL; Benhabbour SR
    Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents.
    Salerno S; Barresi E; Baglini E; Poggetti V; Da Settimo F; Taliani S
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in immunotherapy for glioblastoma multiforme.
    Mahmoud AB; Ajina R; Aref S; Darwish M; Alsayb M; Taher M; AlSharif SA; Hashem AM; Alkayyal AA
    Front Immunol; 2022; 13():944452. PubMed ID: 36311781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma.
    Harder BG; Blomquist MR; Wang J; Kim AJ; Woodworth GF; Winkles JA; Loftus JC; Tran NL
    Front Oncol; 2018; 8():462. PubMed ID: 30406029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glioblastoma multiforme: State of the art and future therapeutics.
    Wilson TA; Karajannis MA; Harter DH
    Surg Neurol Int; 2014; 5():64. PubMed ID: 24991467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs.
    Pirlog BO; Ilut S; Pirlog R; Chiroi P; Nutu A; Radutiu DI; Cuc GD; Berindan-Neagoe I; Nabavi SF; Filosa R; Nabavi SM
    Expert Rev Mol Med; 2023 May; 25():e18. PubMed ID: 37154101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain-targeted Nano-architectures for Efficient Drug Delivery and Sensitization in Glioblastoma.
    Ravuluri JAV; Rao V; Kumar G; Manandhar S; Cheruku SP; Bisht P; Chamallmudi MR; Nandakumar K; Kumar L; Kumar N
    Curr Pharm Des; 2023; 29(22):1775-1790. PubMed ID: 37403389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular targeted therapy: A new avenue in glioblastoma treatment.
    El Atat O; Naser R; Abdelkhalek M; Habib RA; El Sibai M
    Oncol Lett; 2023 Feb; 25(2):46. PubMed ID: 36644133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glioblastoma multiforme: Pathogenesis and treatment.
    Alifieris C; Trafalis DT
    Pharmacol Ther; 2015 Aug; 152():63-82. PubMed ID: 25944528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pericytes in Glioblastomas: Multifaceted Role Within Tumor Microenvironments and Potential for Therapeutic Interventions.
    Sattiraju A; Mintz A
    Adv Exp Med Biol; 2019; 1147():65-91. PubMed ID: 31147872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies.
    Caffery B; Lee JS; Alexander-Bryant AA
    Nanomaterials (Basel); 2019 Jan; 9(1):. PubMed ID: 30654536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug Repositioning in Glioblastoma: A Pathway Perspective.
    Front Pharmacol; ; . PubMed ID: 29615902
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.